Updated Guidelines on Optimal Antibiotic Dosing for Patients With Obesity
Researchers evaluated clinical trial data and drug databases to provide updated recommendations on antimicrobial dosing for patients with obesity.
Diagnosis & Disease Information
Older Age, Prior AMR Risk Factors for Adverse Outcomes in Uncomplicated UTI
Researchers assessed whether adverse outcomes in women with uncomplicated UTI are more likely when initial antibiotic therapy does not cover the causative uropathogen.
FDA Needs More Data on Tebipenem HBr for Complicated UTI
In the CRL, the FDA stated that the application could not be approved in its present form and that an additional clinical trial would be required.
Tebipenem HBr Gets Priority Review for Oral Treatment of Complicated UTI
The application includes data from the phase 3 ADAPT-PO trial, which evaluated the efficacy and safety of tebipenem HBr in 868 adults with cUTI or acute pyelonephritis.
Spero Therapeutics Seeks Approval of Oral Tebipenem HBr for Complicated UTI
The application submission is supported by data from the phase 3 ADAPT-PO trial, which compared oral tebipenem HBr to ertapenem in adults with cUTI or acute pyelonephritis.
Community-Acquired Urinary Tract Infection: Adverse Effects of Cotrimoxazole vs Fluoroquinolones
Investigators conducted a cohort study that compared adverse effects and outcomes among patients with community-acquired urinary tract infection treated with cotrimoxazole vs fluoroquinolones.
Study Supports Shorter Antibiotic Course for Afebrile Men With UTI
The double-blinded, placebo-controlled noninferiority study included a total of 272 afebrile men from 2 US Veterans Affairs medical centers.
FDA Needs More Data on Sulopenem for Uncomplicated UTI
The NDA submission was supported by data from the phase 3 SURE1 clinical trial.
Popular Theory Debunked Regarding Cranberries and UTIs
In female nursing home residents, there was no significant effect on bacteriuria plus pyuria over 1 year in those receiving cranberry capsules.
- Loading...
Loading...
Loading... 
Loading...